Clinical Trial Update: Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating the safety and potential efficacy of allogeneic mesenchymal stem cells in patients with refractory primary biliary c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Robert Chunhua Zhao, MD, PhD | Conditions: Primary Biliary Cirrhosis | Phase 1 | Status: UNKNOWN